Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis

Cambridge, UK; July 31, 2019. Atlantic Healthcare plc (“Atlantic Healthcare” or…


Atlantic Healthcare plc acquires global rights to renzapride for the treatment of gastrointestinal motility disorders

Cambridge, UK; June 26, 2019. Atlantic Healthcare plc (“Atlantic Healthcare” or…


Atlantic Healthcare to attend DDW in San Diego, May 18-21

Cambridge, UK; May 1, 2019. Atlantic Healthcare plc (“Atlantic Healthcare” or…


Atlantic Healthcare to attend BIO-Europe Spring in Vienna, March 23-25

Cambridge, UK; March 12, 2019. Atlantic Healthcare plc (“Atlantic Healthcare”…


Atlantic Healthcare reports results from Phase 1 trial of tablet for Crohn’s

Oral alicaforsen appears safe and well-tolerated Cambridge, UK; 27 September…


Strategic appointment expands Atlantic Healthcare executive team

Cambridge, UK; August 2, 2018. Atlantic Healthcare plc (Atlantic Healthcare), a…